By expenditures
| Name | Title | Type |
|---|---|---|
| Tariro Chapinduka | Director of Business Services | Auditee |
| Chris Knopik | Principal | Auditee |
| Michelle Hoffman, CPA | PRINCIPAL | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 357059 | 2023 | 2025-05-23 | Cliftonlarsonallen LLP | $8.15M |
| 1739 | 2022 | 2023-10-30 | Cliftonlarsonallen LLP | $13.44M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 357059 | 2023 | 2025-05-23 | 1137916 | 2023-006 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137915 | 2023-005 | Material Weakness | - | I |
| 357059 | 2023 | 2025-05-23 | 1137914 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137913 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137912 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137911 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137910 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137909 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 1137908 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561474 | 2023-006 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561473 | 2023-005 | Material Weakness | - | I |
| 357059 | 2023 | 2025-05-23 | 561472 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561471 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561470 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561469 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561468 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561467 | 2023-004 | Material Weakness | - | L |
| 357059 | 2023 | 2025-05-23 | 561466 | 2023-004 | Material Weakness | - | L |
| 1739 | 2022 | 2023-10-30 | 577364 | 2022-005 | Significant Deficiency | - | B |
| 1739 | 2022 | 2023-10-30 | 922 | 2022-005 | Significant Deficiency | - | B |